You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Recurrent diabetic vitreous hemorrhage

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy Trial in Tianjin (Ranibizumab

Recruiting
  • Diabetic Retinopathy
  • +3 more
  • Ranibizumab Injection
  • PPV
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Aug 11, 2022

Diabetic Vitreous Hemorrhage, Tractional Retinal Detachment Trial in Cairo (optical coherence tomography angiography, spectral

Recruiting
  • Diabetic Vitreous Hemorrhage
  • Tractional Retinal Detachment
  • optical coherence tomography angiography
  • spectral domain optical coherence tomography
  • Cairo, Egypt
    KasrAlaini hospital
Feb 11, 2023

Diabetic Vitreous Hemorrhage Trial in Montemorelos (laser)

Recruiting
  • Diabetic Vitreous Hemorrhage
  • laser
  • Montemorelos, Nuevo Leon, Mexico
    La Carlota Hospital
Apr 6, 2022

Proliferative Diabetic Retinopathy Trial in Montemorelos (vitrectomy with sulfur hexafluoride gas, vitrectomy with balanced salt

Active, not recruiting
  • Proliferative Diabetic Retinopathy
  • vitrectomy with sulfur hexafluoride gas
  • vitrectomy with balanced salt solution
  • Montemorelos, Nuevo Leon, Mexico
    La Carlota Hospital
Nov 20, 2021

Proliferative Diabetic Retinopathy, Vitreous Hemorrhage, Tractional Retinal Detachment Trial in Monastir (Bevacizumab Injection

Recruiting
  • Proliferative Diabetic Retinopathy
  • +2 more
  • Bevacizumab Injection [Avastin]
  • Peripheral Retinal Cryoapplication
  • Monastir, Tunisia
    Fattouma Bourguiba University Hospital - Ophthalmology Departmen
Aug 22, 2022

Proliferative Diabetic Retinopathy Trial in Beijing (preoperative group and intraoperative group)

Completed
  • Proliferative Diabetic Retinopathy
  • preoperative group and intraoperative group
  • Beijing, Beijing, China
    People's Hospital of Peking University
Jun 1, 2022

Proliferative Diabetic Retinopathy, Vitreous Hemorrhage Trial in Canada, United States (2-mg Intravitreous Aflibercept

Completed
Has Results
  • Proliferative Diabetic Retinopathy
  • Vitreous Hemorrhage
  • 2-mg Intravitreous Aflibercept Injection
  • Prompt Vitrectomy Plus Panretinal Photocoagulation
  • Campbell, California
  • +61 more
Mar 24, 2021

Proliferative Diabetic Retinopathy Trial in Beijing (preoperative intravitreal injections of ranibizumab or conbercept)

Completed
  • Proliferative Diabetic Retinopathy
  • preoperative intravitreal injections of ranibizumab or conbercept
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 7, 2022

Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant Trial in Tianjin (Ozurdex, Aflibercept)

Not yet recruiting
  • Diabetic Macular Edema
  • +3 more
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Aug 6, 2023

Diabetic Vitreous Hemorrhage Trial in ?awalli (Aflibercept Injection [Eylea], Vitrectomy)

Completed
  • Diabetic Vitreous Hemorrhage
  • Aflibercept Injection [Eylea]
  • Vitrectomy
  • Ḩawallī, Aljabyria, Kuwait
    Alhadi Hospital
Jan 10, 2020

Spontaneous Vitreous Hemorrhage, Retinal Break, Retinal Detachment Trial in Paris (Early vitrectomy)

Recruiting
  • Spontaneous Vitreous Hemorrhage
  • +2 more
  • Early vitrectomy
  • Paris, Ile De France, France
    Hopital Lariboisiere
Nov 21, 2022

Proliferative Diabetic Retinopathy, Vitrectomy Trial in Tianjin (beveled 27G+ vitrectomy system, standard 25G+ vitrectomy

Completed
  • Proliferative Diabetic Retinopathy
  • Vitrectomy
  • beveled 27G+ vitrectomy system
  • standard 25G+ vitrectomy system
  • Tianjin, China
    Tianjin Medical University Eye Hospital
Jan 30, 2023

Diabetic Retinopathy Trial (slow-release dexamethasone implant)

Not yet recruiting
  • Diabetic Retinopathy
  • slow-release dexamethasone implant
  • (no location specified)
Jun 8, 2022

Diabetic Retinopathy Trial in Montemorelos (Intravitreal bevacizumab or intravitreal ziv-aflibercept)

Completed
  • Diabetic Retinopathy
  • Intravitreal bevacizumab or intravitreal ziv-aflibercept
  • Montemorelos, Nuevo Leon, Mexico
    Hospital La Carlota
Nov 20, 2021

Risk Prediction Model for Long-term Low Vision After Vitrectomy

Recruiting
  • Proliferative Diabetic Retinopathy
  • +2 more
    • Tianjin, Tianjin, China
      Tianjin medical university eye hosipital
    Nov 28, 2022

    Non Proliferative Diabetic Retinopathy(NPDR) Trial in Tianjin (pars plana vitrectomy(PPV), Pars plana vitrectomy(PPV)

    Not yet recruiting
    • Non Proliferative Diabetic Retinopathy(NPDR)
    • pars plana vitrectomy(PPV)
    • +2 more
    • Tianjin, China
      Tianjin medical university eye hospital
    May 10, 2023

    Comparing 3 Imaging Systems

    Recruiting
    • Diabetic Retinopathy
    • Topcon Camera
    • +2 more
    • Madison, Wisconsin
      UW Health - University Station Clinic
    Aug 2, 2022

    Diabetic Retinopathy Trial in Nantong (Ranibizumab Injection [Lucentis], Inner limiting membrane stripping, Dexamethasone

    Recruiting
    • Diabetic Retinopathy
    • Ranibizumab Injection [Lucentis]
    • +2 more
    • Nantong, Jiangsu, China
      Affiliated Hospital of Nantong University
    Mar 7, 2022

    Diabetic Retinopathy Trial in Puerto Rico, United States (OTT166, Vehicle control)

    Recruiting
    • Diabetic Retinopathy
    • Peoria, Arizona
    • +65 more
    Jan 25, 2023

    Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Ningbo, Shanghai (drug, other, procedure)

    Unknown status
    • Proliferative Diabetic Retinopathy
    • Diabetic Macular Edema
    • Ningbo, Zhejiang, China
    • +2 more
    Jul 7, 2020

    Diabetic Macular Edema Trial (Bevacizumab Injection [Avastin] (IVB-I), Triamcinolone Acetonide 10mg/mL (IVT-II), Bevacizumab

    Completed
    • Diabetic Macular Edema
    • Bevacizumab Injection [Avastin] (IVB-I)
    • +2 more
    • (no location specified)
    May 24, 2022

    Diabetic Foot Trial in Madrid (2 weeks revision)

    Not yet recruiting
    • Diabetic Foot
    • 2 weeks revision
    • Madrid, Spain
      Clínica Universitaria de Podología de la Universidad Complutense
    Nov 15, 2023

    Diabetic Retinopathy Trial in Puerto Rico, United States (PDS Implant Pre-Filled with 100 mg/mL Ranibizumab, Intravitreal

    Active, not recruiting
    • Diabetic Retinopathy
    • PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
    • Intravitreal Ranibizumab 0.5 mg Injection
    • Dothan, Alabama
    • +75 more
    Aug 3, 2022

    Focal Laser Single Intravitreal Ranibizumab Retinal Artery

    Completed
    • Retinal Artery Macroaneurysm
    • Dual focal laser and intravitreal Ranibizumab injection
    • Cairo, Egypt
      Kasr alainy faculty of medicine
    Jan 29, 2023

    Non-Proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (Faricimab)

    Not yet recruiting
    • Non-Proliferative Diabetic Retinopathy
    • Bakersfield, California
    • +18 more
    Jan 25, 2023